NCT00860353View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551

PHASE1TerminatedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

February 28, 2009

Study Completion Date

May 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD2551

Single dose of oral solution.

DRUG

Placebo

Single dose of oral solution

Trial Locations (1)

Unknown

Research Site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY